Clinical Trial Update: This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples [Phase 1]

View source ↗

Summary

Phase 1 open-label study evaluating pharmacokinetics, safety, and drug–drug interactions of dutasteride and tamsulosin when administered alone and in combinatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• DUTASTERIDE (Dutasteride)
• Tamsulosin (tamsulosin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Prostatic Hyperplasia | Phase 1 | Status: COMPLETED